Product Launch (Blog)

Jun, 28 2023

Advancing Drug Development and Disease Modeling with Pluripotent Stem Cells (PSCs)

Pluripotent stem cells (PSCs) play a pivotal role in biomedical research, offering a versatile platform for studying cellular biology, simulating diseases, and developing new drugs. Through differentiation, PSCs can be transformed into specialized cell types, enabling the evaluation of cardiac and hepatic toxicity. These two factors contribute significantly to drug-related morbidity and mortality, leading to attrition in the drug development pipeline. PSCs are revolutionizing these areas and shaping the future of pharmaceutical research.

According to Data Bridge Market Research the Placental Stem Cells (PSCS) Market accounted for SD 1 billion in 2022, is expected to reach USD 4.91 billion by 2030, at a CAGR of 22% during the forecast period 2023 to 2030.

“Recent advancements in technology”

Recent advancements in genetic engineering have significantly enhanced the capabilities of human pluripotent stem cells (hPSCs). Techniques like directed differentiation, cell tracking, gene function analysis, and gene correction have been improved due to rapid developments in genetic engineering. Nuclease-based technologies, including ZFNs, TALENs, and CRISPR/Cas9, offer high success rates and simplified design, making genetic modifications in hPSCs and their progeny more efficient. These advancements hold promise for accelerating research and applications involving hPSCs in various fields of medicine and biotechnology.

What restraints the growth of the placental stem cells (PSCS) market?

“Growing operating expenses”

Growing operating expenses can pose challenges to the Placental Stem Cells (PSCs) market. Increased expenses, such as research and development costs, manufacturing costs, and regulatory compliance, can impact profit margins and hinder market growth. Companies operating in the PSCs market need to manage and optimize their operating expenses effectively to ensure competitive pricing and sustainable growth in this rapidly evolving sector.

Segmentation:  Placental Stem Cells (PSCS) Market

The placental stem cells (PSCS) market is segmented on the basis of service type and application. 

  • On the basis of service type the placental stem cells (PSCS) market is segmented into sample preservation and storage, sample analysis, sample processing, sample collection and transportation
  • On the basis of application the placental stem cells (PSCS) market is segmented into personalized banking applications, research applications, clinical applications

Regional Insights: North America dominates the Placental Stem Cells (PSCS) Market

North America holds a dominant position in the placental stem cells (PSCS) market due to its well-developed healthcare infrastructure and favorable reimbursement policies. The region's advanced medical facilities, research institutions, and supportive regulatory frameworks contribute to the growth of PSCS market. Additionally, the availability of funding for stem cell research and strong collaborations between academia and industry further strengthen North America's position in this market.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-placental-stem-cells-pscs-market

The Prominent Key Players Operating in the Placental Stem Cells (PSCS) Market Include:

  • CBR Systems, Inc (U.S.)
  • Cordlife India (India)
  • Cryo-Cell International, Inc. (U.S.)
  • ESPERITE N.V. (Netherlands)
  • LifeCell International Pvt. Ltd. (India)
  • StemCyte India Therapeutics Pvt. Ltd (India)
  • PerkinElmer Inc (U.S.)
  • Global Cord Blood Corporation (Hong Kong)
  • Smart Cells International Limited (U.K.)
  • Vita 34 (Germany)

Above are the key players covered in the report, to know about more and exhaustive list of placental stem cells (pscs) market  companies contact, https://www.databridgemarketresearch.com/contact

Research methodology: Global Placental Stem Cells (PSCS) Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.


Client Testimonials